FDA Accepts Submission of New Drug BREXAFEMME That Prevents Vaginal Yeast InfectionsSCYNEXIS has announced that the FDA has accepted the submission for their ibrexafungerp tablets BREXAFEMME. SCYNEXIS’s submission has been granted…
Assessment and management of vaginal bleeding in early pregnancyFaculty: Antay L. Parker, DNP, APRN, WHNP-BC, CNM, CRNFA, C-EFM, is Assistant Professor of Nursing at East Texas Baptist University…
WHNPs as Partners in Addressing the Maternal Health CrisisThere is a well-recognized maternal health crisis in the United States. In 2020, 861 women* died of pregnancy-related complications. This…
Clinical Topics: Reproductive and Sexual HealthDr. Laurie L. Ray, assistant professor (clinical track) at Emory University, Nell Hodgson Woodruff School of Nursing, in Atlanta, Georgia…
FDA approves Pfizer and Myovant’s Endometriosis Drug Myfembree After DelayAfter a delay, the United States Food and Drug Administration has approved the Pfizer and Myovant drug Myfembree. Myfembree is…